Discontinued — last reported Q1 '22

Business Segments · Total net incurred medical claims

Commercial Specialty Business — Total net incurred medical claims

Elevance Health Commercial Specialty Business — Total net incurred medical claims decreased by 10.8% to $6.83B in Q1 2022 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryProfitability
SignalLower is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2022Apr 20, 2022

How to read this metric

Used to calculate the Medical Loss Ratio; lower values relative to revenue indicate higher underwriting profitability.

Detailed definition

This is the aggregate of all net medical claims incurred by the Commercial and Specialty segment, including both current...

Peer comparison

Standard industry metric for total medical expense, comparable across all major health insurance carriers.

Metric ID: elv_segment_commercial_specialty_business_segment_total_net_incurred_medical_claims

Historical Data

4 periods
 Q2 '21Q3 '21Q4 '21Q1 '22
Value$6.72B$7.21B$7.66B$6.83B
QoQ Change+7.4%+6.3%-10.8%
Range$6.72B$7.66B

Frequently Asked Questions

What is Elevance Health's commercial specialty business — total net incurred medical claims?
Elevance Health (ELV) reported commercial specialty business — total net incurred medical claims of $6.83B in Q1 2022.
What does commercial specialty business — total net incurred medical claims mean?
The total net medical claims expense for the segment, including current and prior period adjustments.